Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2009 Nov 12;8(3):289–296.e8. doi: 10.1016/j.cgh.2009.10.034

Table 2.

Hazard ratios for time to cirrhosis in rapid and slow fibrosers.

Variable Unadjusted Hazard Ratio (95% CI) P Value Adjusted Hazard Ratio (95% CI) P Value
Fibrosis Progression
        Slow Reference Reference
        Rapid 132.30 (17.64-950.73) < 0.001 111.19 (14.64-844.47) <0.001
Gender
        Male Reference Reference
        Female 2.40 (1.23-4.66) 0.010 1.15 (0.50-2.65) 0.736
Recipient Agea 0.97 (0.94-1.01) 0.123 1.00 (0.95-1.04) 0.846
Recipient Race
        White Reference
        Black 1.11 (0.52-2.36) 0.783
        Other 1.37 (0.48-3.91) 0.559
Transplant Era
        1992-2002 Reference Reference
        2003-2007 2.18 (1.09-4.37) 0.027 1.20 (0.50-2.91) 0.684
Donor Agea 1.02 (1.00-1.04) 0.030 1.02 (0.99-1.04) 0.127
Acute Rejection Scoreb 2.55 (1.38-4.71) 0.003 1.17 (0.56-2.44) 0.669
Acute Rejection Episodesc 1.55 (1.15-2.09) 0.004
Chronic Rejectiond 3.55 (1.87-6.73) <0.001 1.43 (0.65-3.14) 0.378
Alcohol 0.74 (0.37-1.48) 0.399

Adjusted model includes fibrosis progression, gender, recipient age, transplant era, donor age, rejection score modeled as a time varying covariate and chronic rejection modeled as a dichotomous variable.

a

Hazard ratio corresponds to a one year increase in age.

b

Acute rejection score is modeled as a time varying covariate with the severity of the episode noted at each biopsy being reflected at that time point.

c

Hazard ratio corresponds to a one unit increase in the number of acute rejection episodes.

d

Hazard ratio represents the risk of progression to cirrhosis if a subject ever had chronic rejection noted on a liver biopsy throughout the study period.

HHS Vulnerability Disclosure